1α,25(OH)2-dihydroxyvitamin D3/VDR protects the skin from UVB-induced tumor formation by interacting with the β-catenin pathway.
about
The relevance of the vitamin D endocrine system (VDES) for tumorigenesis, prevention, and treatment of non-melanoma skin cancer (NMSC): Present concepts and future perspectivesVitamin D: a new player in non-alcoholic fatty liver disease?Vitamin D derivatives enhance cytotoxic effects of H2O2 or cisplatin on human keratinocytesPromising therapies for treatment of nonalcoholic steatohepatitis.Vitamin D signaling regulates oral keratinocyte proliferation in vitro and in vivo.The protective role of vitamin d signaling in non-melanoma skin cancer.Targeting cancer stem cells in solid tumors by vitamin D.Novel mechanisms for the vitamin D receptor (VDR) in the skin and in skin cancer.Effects of 1,25(OH)2D3 on proliferation and apoptosis of human glomerular mesangial cells.Role of Vitamin D in Uremic Vascular Calcification.Vitamin D Is a Multilevel Repressor of Wnt/b-Catenin Signaling in Cancer Cells.Interaction of vitamin D with membrane-based signaling pathwaysVitamin D receptor, a tumor suppressor in skin.Novel non-calcemic secosteroids that are produced by human epidermal keratinocytes protect against solar radiation.Role of vitamin D in cytotoxic T lymphocyte immunity to pathogens and cancer.LncRNA: a new player in 1α, 25(OH)(2) vitamin D(3) /VDR protection against skin cancer formation.Depleting ovarian cancer stem cells with calcitriol.Role of vitamin D receptor gene polymorphisms in pancreatic cancer: a case-control study in China.No effects without causes: the Iron Dysregulation and Dormant Microbes hypothesis for chronic, inflammatory diseases.
P2860
Q27004135-FF30CDE1-B887-4DA8-AA0C-C740E2CC6612Q28081391-93D16EBC-F951-421C-BBDF-63C704ED82C1Q28393501-7A26B655-A57B-40F5-BC2A-098FE43F5120Q30248578-56AF9935-F74A-4F62-A950-828A05756629Q33637048-EB475DE5-2FE6-4A1E-8AD9-1DD7B389FECEQ35033717-3C60CC67-9F24-4037-8280-69D7A3EA2887Q35181108-A6177D8F-A78C-4F23-A2B4-132A6757CEB5Q35181186-C7B0A488-5FF7-42A5-9030-0D3B1B58E261Q37060783-113A5D23-8E63-49BB-B481-1210959034FFQ37670797-C88EF81E-35FF-401E-ABED-0BB39A3153C5Q38160744-665F43B0-AA35-4641-98B3-C14B48410DD5Q38193801-965E78B3-BC91-49FC-B09A-8E776D467BA8Q38307555-AA1FF48F-9B4F-4789-AE4E-02DE3D4FE60AQ38330836-F1E47DED-2860-4E8B-9C9E-77B2FB06A9AAQ38610901-A582F8BF-EB28-4F39-B503-BDCB2D520683Q42255026-5A740C2E-7A9A-4F98-82E7-DD1D874E0352Q52629170-B8DAD45D-08DB-42D6-B340-78525CFD4CAFQ53636755-A0AB41F0-6D50-4140-AC5D-CD3BAD6DB25CQ53698735-EF084C47-ED80-4B39-9138-C61C36AE72C1
P2860
1α,25(OH)2-dihydroxyvitamin D3/VDR protects the skin from UVB-induced tumor formation by interacting with the β-catenin pathway.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
1α,25(OH)2-dihydroxyvitamin D3 ...... ng with the β-catenin pathway.
@en
type
label
1α,25(OH)2-dihydroxyvitamin D3 ...... ng with the β-catenin pathway.
@en
prefLabel
1α,25(OH)2-dihydroxyvitamin D3 ...... ng with the β-catenin pathway.
@en
P2093
P2860
P1476
1α,25(OH)2-dihydroxyvitamin D3 ...... ng with the β-catenin pathway.
@en
P2093
Arnaud E Teichert
Daniel D Bikle
Frankie Fong
Yan J Jiang
P2860
P304
P356
10.1016/J.JSBMB.2012.09.024
P577
2012-09-28T00:00:00Z